PDGFA gene rs9690350 polymorphism increases biliary atresia risk in Chinese children

Biosci Rep. 2020 Jul 31;40(7):BSR20200068. doi: 10.1042/BSR20200068.

Abstract

Biliary atresia (BA) is a genetic and severe fibro-inflammatory obliterative cholangiopathy of neonates. Platelet-derived growth factor subunit A (PDGFA), as one of participants in liver fibrosis, the overexpression of PDGFA through DNA hypomethylation may lead to the development of BA, but the pathogenesis is still unclear. We conducted a large case-control cohort to investigate the association of genetic variants in PDGFA with BA susceptibility in the Southern Chinese population (506 cases and 1473 controls). We observed that the G allele of rs9690350(G>C) in PDGFA was significantly associated with an increased risk of BA (OR = 1.24, 95% CI = 1.04-1.49, P=0.02). Additionally, the rs9690350 G allele increased the risk of non-cystic biliary atresia (OR = 1.26, 95% CI = 1.04-1.52, P=0.02) and was a genetic biomarker of severe manifestations after surgery. These findings indicate that the rs9690350 G allele is a PDGFA polymorphism associated with the risk of BA that may confer increased disease susceptibility.

Keywords: GWAS; PDGFA; biliary atresia; polymorphism; susceptibility.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian People / genetics
  • Biliary Atresia / diagnosis
  • Biliary Atresia / epidemiology
  • Biliary Atresia / genetics*
  • Biliary Atresia / surgery
  • Biomarkers
  • Case-Control Studies
  • China / epidemiology
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Infant
  • Male
  • Platelet-Derived Growth Factor / genetics*
  • Polymorphism, Single Nucleotide
  • Risk Assessment / statistics & numerical data
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Biomarkers
  • Platelet-Derived Growth Factor
  • platelet-derived growth factor A